Abstract: The present invention provides genetic markers on human chromosome 19 that are associated with a beneficial response to interferon alpha (IFN-?). These IFN-? response markers are useful, inter alia, to identify patients who are most likely to benefit from treatment with IFN-? pharmaceutical compositions and drug products, in methods of treating patients having a disease susceptible to treatment with an IFN-?, and in methods for selecting the most appropriate therapy for such patients.

Abstract: A method for fabricating a back electrode type solar cell include the steps of applying a solution including a compound containing first conductivity type impurities, titanium alkoxide, and alcohol to a surface of a first conductivity type silicon substrate, and forming a light-receiving face diffusion layer and an anti-reflection film by subjecting the solution to heat treatment in a nitrogen atmosphere. There is also provided a back electrode type solar cell including a light-receiving face diffusion layer having a sheet resistance greater than or equal to 100 ?/ and less than 250 ?/.

Abstract: A fluorescent material-sealed sheet includes a plurality of fluorescent sections, an upper sealing section, and a lower sealing section, the plurality of fluorescent sections being sealed by the upper sealing section and the lower sealing section.

Abstract: The present invention provides an image encoding device that can balance encoding at a high compression ratio and restoration of a high-quality image by decoding in a short processing time. Compression mode determination means 3 determines a compression mode to be one of DPCM and PCM based on target pixel data inputted from a terminal 21 and predicted data calculated by a predetermined method. For the DPCM, DPCM compression means 5 compresses a difference value between the target pixel data and the predicted data to DPCM encoded data having a predetermined DPCM code length. For the PCM, PCM compression means 7 compresses the target pixel data to PCM encoded data having a PCM code length determined by PCM code length determination means 9. The PCM code length determination means 9 calculates the PCM code length for each piece of target pixel data such that a total of post-encoding code lengths becomes an allowable value or less in a unit of predetermined pixel group among the plurality of pixels.

Abstract: The width W1 of a groove (5a) is formed narrower than the width W2 of a groove (6a). The width W2 of the groove (6a) is formed at a prescribed width such that a sealing material (8) that overflows the groove (5a) can be formed along the groove (6a). The sealing material (8) spreads across the entirety of the groove (5a) and the groove (6a) when a color filter substrate (2) and an active matrix substrate (3) are bonded together. The groove (5a) is formed so as to be positioned within the groove (6a) in a plan view.

Abstract: A vapor deposition source (60), a limiting plate unit (80), and a vapor deposition mask (70) are disposed in this order. The limiting plate unit includes a plurality of limiting plates (81) disposed along a first direction. At least a portion of surfaces (83) defining a limiting space (82) of the limiting plate unit and surfaces (84) of the limiting plate unit opposing the vapor deposition source is constituted by at least one outer surface member (110, 120) capable of attaching to and detaching from a base portion (85). Accordingly, a vapor deposition device that is capable of forming a coating film in which edge blur is suppressed on a large-sized substrate and that has excellent maintenance performance can be obtained.

Abstract: Provided is an illumination device capable of housing and fixing a plurality of light guide plates inside a chassis. The illumination device has a rectangular box-shaped chassis, a plurality of horizontally long rectangular light guide plates that are housed inside the chassis while arranged side by side on the bottom surface, light sources that emit light to the shorter side end faces of the respective light guide plates such that the light enters the respective light guide plates, and a plurality of support members that clamp the respective light guide plates on the bottom surface of the chassis. Each support member has a holding part that makes contact with upper surfaces of respective light guide plates at the long-side edges, a shank extending from the holding part, and a pair of locking pieces elastically deformable toward and away from each other, the pair of locking pieces being provided at an end of the shank and being inserted and engaged in an attachment hole in the bottom plate.

Abstract: A system for determining impedance includes receiving a time varying voltage signal from a biosensor and receiving a time varying current signal from the biosensor. The time varying voltage signal and the time varying current signal are transformed to a domain that represents complex impedance values. Calculating parameters based upon the impedance values in a manner suitable to automatically select a first endpoint of an analysis aperture in a region of interest.

Abstract: There is provided a nitride semiconductor light emitting device having a light emitting portion coated with a coating film, the light emitting portion being formed of a nitride semiconductor, the coating film in contact with the light emitting portion being formed of an oxynitride film deposited adjacent to the light emitting portion and an oxide film deposited on the oxynitride film. There is also provided a method of fabricating a nitride semiconductor laser device having a cavity with a facet coated with a coating film, including the steps of: providing cleavage to form the facet of the cavity; and coating the facet of the cavity with a coating film formed of an oxynitride film deposited adjacent to the facet of the cavity and an oxide film deposited on the oxynitride film.

Abstract: The present invention provides compounds of Formula (I): and tautomers, isomers, and esters of said compounds, and pharmaceutically acceptable salts, solvates, and pro-drugs of said compounds, wherein each of R, R1, X, Y, Z, R2, R3, R4, R5, R6, R7, R8, R9, R18, R19 and n is selected independently and as defined herein. Compositions comprising such compounds are also provided. The compounds of the invention are effective as inhibitors of HCV, and are useful, alone and together with other therapeutic agents, in treating or preventing diseases or disorders such as viral infections and virus-related disorders.

Abstract: The present invention is directed to imidazoisoindole compounds which are antagonists of neuropeptide S receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which the neuropeptide S receptor is involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the neuropeptide S receptor is involved.

Abstract: The present invention relates to the signaling of channel quality information in a multi-beam transmission system, wherein a plurality of sets of channel quality information are transmitted for controlling the transmission rate on one of the beams, wherein each set of channel quality information is derived dependent on an assumed parameter of at least one other beam which could be transmitted, comprising selecting a parameter of the transmission of each of the sets of channel quality information dependent on the assumed parameter of the at least one other beam.

Abstract: Aspects of the present invention are related to systems and methods for parallel video encoding and decoding.

Abstract: Systems and methods of manipulating display parameters of displayed images, and optionally designating the images for manipulation, via a gesture pad.

Abstract: In its many embodiments, the present invention provides certain 2-imino-3-methyl pyrrolo pyrimidone compounds, including compounds Formula (II): and include tautomers, steroisomers, or pharmaceutically acceptable salts or solvates of said compounds, stereoisomers, or said tautomers, wherein R2, R3, R4, R5, R6, R7, R8, and R9 are each selected independently and as defined herein. Pharmaceutical compositions comprising one or more such compounds, and methods for their preparation and use in treating pathologies associated with amyloid beta (A?) protein, including Alzheimer's Disease, are also disclosed.

Abstract: This invention relates to compounds of the Formula (I): (Chemical formula should be inserted here as it appears on abstract in paper form) (I) or a pharmaceutically acceptable salt, solvate or isomer thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, ADAMs, TACE, aggrecanase, TNF—or combinations thereof.

Abstract: A color conversion film is disclosed that absorbs light from an organic electroluminescent part emitting blue-green light and converts the light to visible light at a longer wavelength. The color conversion film includes two different dyes. A first dye is a polymer dye with an average molecular weight of 1000 to 1,000,000 that absorbs light incident on the color conversion film and transfers the energy of the light to a second dye. The second dye is a dye that receives the energy from the first dye and emits light. With a multicolor-emitting, organic electroluminescent device including the color conversion film, it is possible to achieve excellent conversion efficiency without increasing the thickness of the color conversion film as in a conventional device using a binder resin.

Abstract: To provide a control unit including a touch panel display capable of presenting preview display of multiple pages of document images on the display panel, the touch panel display includes: a binding position indicating controller; a binding process preview displaying controller that displays preview images of recording paper bound at the specified position; a paper binding position-linked scrolling display switching controller that, when the binding position in the printed paper is modified, switches the direction of scrolling preview display so as to be suited to the recording paper bound at the modified binding position.

Abstract: A semiconductor device comprising at least two wiring layers on a substrate or a surface layer of the substrate, wherein a lower wiring layer of the two wiring layers contains silicon, and a silicon carbide layer is placed between the lower wiring layer and an upper wiring layer.

Abstract: A direct-viewing type display device (100A) of the present invention includes: a display panel which has a display region (10A) that can be altered into a transparent state and a frame region (10F) provided outside the display region; and a light-transmitting cover (20) provided on a front side of the display panel. The light-transmitting cover includes a lens portion (22) positioned so as to overlap a region that includes part of the frame region of the display panel and part of a peripheral display region (10D) within the display region which adjoins the part of the frame region. The display device further includes a housing (30) which has a housing portion (36) provided at least on a side surface (10b) of the display panel. Part of light going out from the part of the peripheral display region and/or part of light entering the housing portion on a rear side goes out on a front side of the housing portion (36).